LY210073 is primarily utilized in the field of neuroscience research, particularly in studies focusing on the central nervous system. It is often employed to investigate the role of specific receptors in neurological disorders, such as schizophrenia and Parkinson's disease. Researchers use it to understand the mechanisms of receptor modulation and its potential therapeutic effects. Additionally, LY210073 is valuable in preclinical studies aimed at developing new treatments for cognitive and motor dysfunctions. Its application helps in exploring the efficacy and safety of targeting certain pathways in the brain, contributing to advancements in neuropharmacology.